← Eichor
Study identifier: NCT06118567 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Nitrous Oxide on Aggression.

Condition: Intermittent Explosive Disorder  ·  Sponsor: Ohio State University

PhasePhase 2
Planned participants50
Who can joinAll sexes, 21 Years to 55 Years
Healthy volunteersYes

About this study

The goal of this experimental medicine clinical trial is to test the hypothesis that nitrous oxide inhalation will result in a change in neurocircuit function in healthy controls and in individuals with impulsive aggressive tendencies. The main question aims to answer are: Does Nitrous Oxide normalize brain circuit function in impulsively aggressive individuals 24 hours after inhalation. Participants will undergo a 60 minute inhalation session with 50% Nitrous Oxide (or room air at another session) and then undergo an fMRI scan 24 hours later. Researchers will compare healthy controls and impulsively aggressive individuals to see if Nitrous Oxide can normalize the function of cortico-limbic circuits in the latter group.

This description comes directly from the study's public registry record.

Talk to the study team

Jayla Copland, B.A.  ·  614-327-1707  ·  jayla.copland@osumc.edu

Julian Roberts, R.N.  ·  julian.roberts@osumc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Ohio State University Wexner Medical CenterColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06118567